Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients

Table 1 Demographic and clinical parameters of evaluable mCRPC patients

Data between parentheses are percentage
AP alkaline phosphatase; CTC circulating tumor cell; PSA prostate-specific antigen
^a At time of enrollment. Not available for three patients due to unavailability of pathological results
^b Patients with suspicious lesions under investigation at the time of study enrollment

ISSN: 1479-5876